12:30 Tue 24 Aug 2021
Director/PDMR Shareholding
DXS INTERNATIONAL PLC
Notification of Director / PDMR Dealing
The Board of DXS International plc (the “Company”), the AQSE Growth Market quoted clinical decision support developer and supplier of clinical decision support systems has received notification that on
Following the transaction specified above
1 | Details of the person discharging managerial responsibilities / person closely associated | ||||
a) | Name | ||||
2 | Reason for the notification | ||||
a) | Position/status | Chairman | |||
b) | Initial notification /Amendment | Initial | |||
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||||
a) | Name | DXS INTERNATIONAL PLC | |||
b) | LEI | 2138001R1KEUWTXEVJ44 | |||
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||||
a) | Description of the financial instrument, type of instrument | Ordinary Shares of 0.33p each | |||
Identification code | ISIN GB00B2Q6HZ92 | ||||
b) | Nature of the transaction | Purchase | |||
c) | Price(s) and volume(s) | ||||
Price(s) | Volume(s) | ||||
12.8p | 10,156 | ||||
d) | Aggregated information | ||||
- Aggregated volume | |||||
- Price | |||||
e) | Date of the transaction | ||||
f) | Place of the transaction | AQSE |
The Directors of DXS International plc accept responsibility for this announcement
Enquiries:
DXS International plc | 01252 719800 david@dxs-systems.com |
Wrecclesham House Farnham Surrey GU10 4PS | |
www.dxs-systems.co.uk |
Corporate Advisor | |
City & Merchant | 0207 101 7676 |
Corporate Broker | |
Hybridan LLP | 020 3764 2341 |
Note to Editors:
DXS International presents up to date treatment guidelines and recommendations, from Clinical Commissioning Groups and other trusted NHS sources, to doctors, nurses and pharmacists in their workflow and during the patient consultation. This effective clinical decision support ultimately translates to improved healthcare outcomes delivered more cost effectively which should significantly contribute towards the NHS achieving its projected efficiency savings.
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of...
FOR OUR FULL DISCLAIMER CLICK HERE